Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Recipients of primary liver (cadaver/liver, whole/segmental) transplants 5- 30 years old.~* Rejection-free post-transplant course for at least 3 months~* Renal dysfunction (15% decrease in age-adjusted calculated creatinine clearance)~* Hypertension requiring anti-hypertensive mediations.~* Informed consent.~* Weight ≥15 kg.~Exclusion Criteria:~* Rejection or infections within 3 months of enrollment.~* Intent to continue TAC~* Active participation in ongoing studies of immunosuppressive agents.~* Lack of informed consent.~* Pregnant or breast feeding~* HIV positive

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Sirolimus (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).